Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 654

Results For "ED"

11145 News Found

BI Sky Global successfully completes FDA MoCRA registration
Drug Approval | August 25, 2024

BI Sky Global successfully completes FDA MoCRA registration

MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States


Zydus to acquire 50% stake in Sterling Biotech from Perfect Day
News | August 24, 2024

Zydus to acquire 50% stake in Sterling Biotech from Perfect Day

The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets


Sun Pharma introduces STARIZO in India for skin infections
News | August 23, 2024

Sun Pharma introduces STARIZO in India for skin infections

Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India


Lupin receives Health Canada approval for biosimilar Pegfilgrastim
News | August 23, 2024

Lupin receives Health Canada approval for biosimilar Pegfilgrastim

Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim


Wanbury receives EIR from FDA for Patalganga facility
Drug Approval | August 23, 2024

Wanbury receives EIR from FDA for Patalganga facility

USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation


Nephro Care India reports 86.07% jump in PAT at Rs 4.41 crore during FY 23-24
News | August 23, 2024

Nephro Care India reports 86.07% jump in PAT at Rs 4.41 crore during FY 23-24

Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line


BioAge appoints former GSK CEO Jean-Pierre Garnier as Chair of its Board of Directors
People | August 23, 2024

BioAge appoints former GSK CEO Jean-Pierre Garnier as Chair of its Board of Directors

New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development


Roche responds to WHO’s declaration of health emergency due to mpox outbreak
Healthcare | August 23, 2024

Roche responds to WHO’s declaration of health emergency due to mpox outbreak

Roche confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants


Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
News | August 23, 2024

Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target

This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties